NSE: SPARC - Sun Pharma Advanced Research Company Limited

Yield per half year: -38.58%
Sector: Healthcare

Sun Pharma Advanced Research Company Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 59.31 -100% -29.86 -100%
P/S 161.88 8.62 1778.63%
P/BV 97.25 6.53 1389.16%
P/FCF -14.41 0.6184 -2430.55%
Ev/Ebitda -30.18 141.72 -121.3%
Ev/S 160.63 8.63 1761.01%
Ev/FCF -27.9 7.72 -461.42%
E/P -0.0618 0.1367 -145.19%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-532.23 0.3647 -146026.33% -241.32 +120.55%
ROE -307.92 7.22 -4363.62%
ROA -75.18 6.7 -1222.68%
ROIC 0 15.91 -100%
ROS -512.52 -4.66 10887.02%
ROCE -329.71 11.71 -2915.75%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.1521 123.39 -100.12% -0.5379 -71.73%
Nеt Debt/Ebitda 0.2342 121.88 -99.81%
Debt/Ratio 0.1187 0.1698 -30.07%
Debt/Equity 0.57 3.45 -83.45%
Debt/Net Income -0.1579 3.06 -105.16%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 9.59 -100% 0 0%
Number of years of dividend growth 0 0.7073 -100%
DSI 0 0.8351 -100%
Average dividend growth 0 -2.19 -100%
Average percentage for 5 years 0 14.83 -100%
Average percentage for payments 0 24.67 -100%
Difference from average difference in sector -9.59

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-1.65 695.45 -100.24%
Growth impulse Ebitda in 5 years 30.96 617.6 -94.99%
Growth impulse Net Income in 5 years 23.95 759.48 -96.85%
Growth impulse FCF in 5 years 64.22 1011.9 -93.65%
Growth impulse EPS in 5 years 2.32 220.4 -98.95%
IP Score
3.08/10

Similar companies

Glenmark Pharmaceuticals Limited

Piramal Enterprises Limited

Biocon Limited

IndusInd Bank Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription